MEDF — Medfield Diagnostics AB Share Price
Last trade - 00:00- SEK17.93m
- SEK10.82m
- SEK0.71m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.24 | ||
| Price to Tang. Book | 2.08 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 25.15 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -18.82% | ||
| Return on Equity | -20.52% | ||
| Operating Margin | -1947.55% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 0.85 | 1.2 | 0.4 | 2.4 | 0.71 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Medfield Diagnostics AB is a Sweden-based developer of medical instrumentation. The Company develops, markets and sells diagnostic instrumentation based on microwave technology. The Company's microwave technology complements other imaging principles in two main ways. Firstly microwaves sense dielectric properties and provide high contrast for biological matter with different water content, thus enabling diagnosis of for example blood in brain tissue or tumors in breast tissue. Secondly microwave instruments are compact and thus used earlier in the healthcare chain, in emergency rooms and in ambulances. The Company’s products include R10; the M100, available on stroke services for night-time surveillance of patients at increased risk of stroke, as well as D1000 that is a diagnostic instrument for use in emergency rooms and ambulances to diagnose the type of stroke, ischemic (blood clot) or hemorrhagic (bleeding).
Directors
- Mikael Persson CHM
- Stefan Blomsterberg CEO
- Andreas Fhager CFD
- Hakan Hornell VBD
- Claes Beckman DRC (56)
- Erik Brobjer DRC
- Jan Ellevset DRC
- Stefan Jacobsson DRC
- Bengt-Arne Sjoqvist DRC
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- March 14th, 2005
- Public Since
- May 2nd, 2012
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- AktieTorget Stock Exchange
- Shares in Issue
- 79,345,155
- Address
- Medicinaregatan 8B, GOETEBORG, 413 90
- Web
- https://www.medfielddiagnostics.com/
- Phone
- +46 31160668
- Auditors
- Frejs Revisorer AB
Upcoming Events for MEDF
Similar to MEDF
AlphaHelix Molecular Diagnostics AB (publ)
AktieTorget Stock Exchange
Alteco Medical AB
AktieTorget Stock Exchange
Audientes A/S
AktieTorget Stock Exchange
BibbInstruments AB
AktieTorget Stock Exchange
Inhalation Sciences Sweden AB
AktieTorget Stock Exchange
FAQ
As of Today at 19:14 UTC, shares in Medfield Diagnostics AB are trading at SEK0.23. This share price information is delayed by 15 minutes.
Shares in Medfield Diagnostics AB last closed at SEK0.23 and the price had moved by -93.1% over the past 365 days. In terms of relative price strength the Medfield Diagnostics AB share price has underperformed the FTSE Global All Cap Index by -93.52% over the past year.
There is no consensus recommendation for this security.
Medfield Diagnostics AB does not currently pay a dividend.
Medfield Diagnostics AB does not currently pay a dividend.
Medfield Diagnostics AB does not currently pay a dividend.
To buy shares in Medfield Diagnostics AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK0.23, shares in Medfield Diagnostics AB had a market capitalisation of SEK17.93m.
Here are the trading details for Medfield Diagnostics AB:
- Country of listing: Sweden
- Exchange: AKT
- Ticker Symbol: MEDF
Based on an overall assessment of its quality, value and momentum Medfield Diagnostics AB is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medfield Diagnostics AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -28.77%.
As of the last closing price of SEK0.23, shares in Medfield Diagnostics AB were trading -44.9% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Medfield Diagnostics AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK0.23.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Medfield Diagnostics AB's management team is headed by:
- Mikael Persson - CHM
- Stefan Blomsterberg - CEO
- Andreas Fhager - CFD
- Hakan Hornell - VBD
- Claes Beckman - DRC
- Erik Brobjer - DRC
- Jan Ellevset - DRC
- Stefan Jacobsson - DRC
- Bengt-Arne Sjoqvist - DRC